Skip to main content

$0.085 -0.001 (-1.16%)

High

$0.09

Low

$0.09

Trades

15

Turnover

$18,591

Volume

214,739
30 June 2023 at 3:31pm
Register to track OSX and receive email alerts.
Subject
OSX Ann: Cleansing Notice

OSX Ann: Application for quotation of securities - OSX

OSX Ann: Notification of cessation of securities - OSX

OSX Ann: Reinstatement to Official Quotation

OSX Ann: Proposed issue of securities - OSX

OSX Ann: Firm Commitments and Non-Binding Proposed Acquisition

OSX Ann: Suspension from Official Quotation

OSX Ann: Trading Halt

OSX Ann: Increased presence and commercial opportunities across SEA

OSX Ann: Activities Update Qtr Ending September 2022 and Appendix 4C

OSX Ann: Ceasing to be a substantial holder

OSX Ann: Change in substantial holding

OSX Ann: Chile Government and University co-fund Osteopore research

OSX Ann: More Osteopore Products Available on Prostheses List

OSX Ann: Half Yearly Report and Accounts

OSX Ann: Change in substantial holding

OSX Ann: Becoming a substantial holder

OSX Ann: Osteopore Moves Closer to China Market Entry

OSX Ann: Investor Presentation

OSX Ann: Osteopore Gains Access to US Federal Healthcare Facilities

OSX Ann: SHG: Clarification regarding collaboration with OSX

OSX Ann: SHG: Collaborative Agreement signed with OSX

OSX Ann: Osteopore to Leverage on AI/VR to Enhance Market Access

OSX Ann: Activities Update Qtr Ending June 2022 and Appendix 4C

OSX Ann: Notification of cessation of securities - OSX

OSX Ann: Change of Director's Interest Notice

OSX Ann: Collaboration With Healthcare Group To Develop New Products

OSX Ann: Change of Director's Interest Notice

OSX Ann: OSX Expands into Africa with Initial Sales to South Africa

OSX Ann: Constitution

OSX Ann: Employee Securities Incentive Plan

OSX Ann: Results of Annual General Meeting

OSX Ann: OSX Enter Oral & Maxillofacial Market in Australia & NZ

OSX Ann: Notice of Annual General Meeting

OSX Ann: Activities Update Qtr Ending March 2022 and Appendix 4C

OSX Ann: Appointment of Chief Operating Officer

OSX Ann: OSX Expands Further into Europe with Initial Sales to Spain

OSX Ann: Annual General Meeting Date

OSX Ann: OSX Expands to Latin America with Initial Sales to Colombia

OSX Ann: Appendix 4G and Corporate Governance Statement

OSX Ann: Annual Report to shareholders

OSX Ann: OSX Commences AI-Powered Design Study for Cranial Implants

OSX Ann: SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures

OSX Ann: Appendix 4E Preliminary Final Report

OSX Ann: Notification of cessation of securities - OSX

OSX Ann: Appendix 3Y

OSX Ann: Appendix 3Z

OSX Ann: Resignation of Non-Executive Director

OSX Ann: Activities Update Qtr Ending December 2021 and Appendix 4C

OSX Ann: Chief Financial Officer Resignation

Register to track OSX and receive email alerts.

Similar Companies

ANN
AVR
MGZ
NAN
NXS
PNV
SDI
SDI